Skip to main content
. 2015 Feb 11;473(7):2300–2304. doi: 10.1007/s11999-015-4174-4

Table 2.

Univariate analysis of data collected from patients with a history of PJI after their initial arthroplasty

Factors No secondary PJI (n = 80/90) Secondary PJI (n = 10/90) Mean/percent difference p value
Age (years) (mean ± SD) 61 ± 11 59 ± 12 2.2 0.623
Female sex (%) 40/80 (50%) 9/10 (90%) OR = 8.83 (95% CI, 1.13–403.33) 0.02*
Body mass index (kg/m2) (mean ± SD) 32 ± 7 34 ± 6 1.9 0.402
Diabetes (%) 14% 20% 6% 0.622
American Society of Anesthesiologists 0.093
 1 1 0
 2 28 0
 3 32 7
 4 0 0
Charlson Comorbidity Index (mean ± SD) 4 ± 1 3 ± 1 0.2 0.604
Time from diagnosis of initial PJI to second arthroplasty (months) (mean ± SD) 35 ± 33 22 ± 23 13 months 0.218
Treatment of initial PJI with I&D 19%
(n = 15)
20%
(n = 2)
1% 0.640
(all treatments compared)
Treatment of initial PJI with single-stage exchange 11%
(n = 9)
10%
(n = 1)
1 0.640
(all treatments compared)
Treatment of initial PJI with two-stage exchange 56%
(n = 45)
70%
(n = 7)
14% 0.640
(all treatments compared)
Treatment of initial PJI with more than one technique 14%
(n = 11)
0%
(n = 0)
14% 0.640
(all treatments compared)
Patients treated with chronic suppressive antibiotics before second arthroplasty 0%
(n = 0)
0%
(n = 0)
0% 1.00
Initial infecting organism (staphylococcus species) 35%
(n = 28)
70%
(n = 7)
OR = 4.26 (95% CI, 0.89–27.50) 0.032*
Initial infecting organism (resistant staphylococcus species) 15%
(n = 12)
20%
(n = 2)
5.0% 0.681
Second PJI infecting organism (staphylococcus species) N/A 80%
(n = 8)
N/A N/A
Second infecting organism (resistant staphylococcus species) N/A 10%
(n = 1)
N/A N/A
Initial and subsequent PJI on ipsilateral limb N/A 0%
(n = 0)
N/A N/A
Date of initial PJI (> year 2000) 898%
(n = 71)
100%
(n = 10)
11.2% 0.590

* Significant; PJI = periprosthetic joint infection; I&D = irrigation and débridement; OR = odds ratio; CI = confidence interval; N/A = not applicable.